Immunogenetic profile of multiple sclerosis in Mexicans - PubMed (original) (raw)
Comparative Study
Immunogenetic profile of multiple sclerosis in Mexicans
C Gorodezky et al. Hum Immunol. 1986 Aug.
Abstract
This is the first study on genetic markers in Mexican Mestizos with multiple sclerosis (MS). Patients were born in Mexico, had no family history of MS are middle-class, and have a high-level education. HLA class I, class II determinants, C2, C4, BF, GLO-1, ABO, and Rb red cell systems were analyzed and compared with results of 295 controls. Measles antibodies, glucose, IgG, total proteins, and cell count were measured in cerebrospinal fluid; anti-neuron, T-cell, and B-cell antibodies were determined in serum. MS in Mexican Mestizos was clinically similar to MS reported in high prevalence countries. DRw6, as previously found in Japanese patients, and its subtype, DRw13, were increased in patients in our study (pc = 0.0007, pc = 0.01, respectively), and the combination A3, B7, DR2, was also elevated (pc = 0.003). The polygenicity of the disease is emphasized by the excess of AB group carriers (pc = 0.01). IgG levels were high in patients with DR2 or DRw6 and 67% of the latter had anti-T cell antibodies. Severity of the disease was also related to the DR markers. It is suggested that at least two HLA-DR linked genes and the industrialized environment are important for the expression of MS in Mestizos.
Similar articles
- HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis.
Alvarado-de la Barrera C, Zúñiga-Ramos J, Ruíz-Morales JA, Estañol B, Granados J, Llorente L. Alvarado-de la Barrera C, et al. Neurology. 2000 Dec 26;55(12):1897-900. doi: 10.1212/wnl.55.12.1897. Neurology. 2000. PMID: 11134391 - HLA and multiple sclerosis: population and families study.
Govaerts A, Gony J, Martin-Mondiére C, Poirier JC, Schmid M, Schuller E, Degos JD, Dausset J. Govaerts A, et al. Tissue Antigens. 1985 Apr;25(4):187-99. doi: 10.1111/j.1399-0039.1985.tb00436.x. Tissue Antigens. 1985. PMID: 3874450 - [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R, Madigand M, Gueguen-Duchesne MY, Papin J, Sabouraud O, Genetet B. Fauchet R, et al. Rev Neurol (Paris). 1984;140(6-7):422-5. Rev Neurol (Paris). 1984. PMID: 6611572 French. - Association of HLA and multiple sclerosis.
Martin R, Vogt AB, Kropshofer H, Lichtenfels R. Martin R, et al. Behring Inst Mitt. 1994 Jul;(94):158-70. Behring Inst Mitt. 1994. PMID: 7998908 Review. - [Current problems in multiple sclerosis (immunogenetic aspect) (review of the literature)].
Khondkarian OA, Zavalishin IA. Khondkarian OA, et al. Zh Nevropatol Psikhiatr Im S S Korsakova. 1978;78(2):292-300. Zh Nevropatol Psikhiatr Im S S Korsakova. 1978. PMID: 76384 Review. Russian. No abstract available.
Cited by
- Heterogeneity of Genetic Admixture Determines SLE Susceptibility in Mexican.
Hernández-Doño S, Jakez-Ocampo J, Márquez-García JE, Ruiz D, Acuña-Alonzo V, Lima G, Llorente L, Tovar-Méndez VH, García-Silva R, Granados J, Zúñiga J, Vargas-Alarcón G. Hernández-Doño S, et al. Front Genet. 2021 Aug 3;12:701373. doi: 10.3389/fgene.2021.701373. eCollection 2021. Front Genet. 2021. PMID: 34413879 Free PMC article. - Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.
Sospedra M, Muraro PA, Stefanová I, Zhao Y, Chung K, Li Y, Giulianotti M, Simon R, Mariuzza R, Pinilla C, Martin R. Sospedra M, et al. J Immunol. 2006 Feb 1;176(3):1951-61. doi: 10.4049/jimmunol.176.3.1951. J Immunol. 2006. PMID: 16424227 Free PMC article. - Epidemiologic evidence for multiple sclerosis as an infection.
Kurtzke JF. Kurtzke JF. Clin Microbiol Rev. 1993 Oct;6(4):382-427. doi: 10.1128/CMR.6.4.382. Clin Microbiol Rev. 1993. PMID: 8269393 Free PMC article. Review. - HLA and prognosis in multiple sclerosis.
Runmarker B, Martinsson T, Wahlström J, Andersen O. Runmarker B, et al. J Neurol. 1994 May;241(6):385-90. doi: 10.1007/BF02033356. J Neurol. 1994. PMID: 7931434 - Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L. Valli A, et al. J Clin Invest. 1993 Feb;91(2):616-28. doi: 10.1172/JCI116242. J Clin Invest. 1993. PMID: 7679413 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous